{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:43:53Z","timestamp":1787863433861,"version":"build-2784847793"},"reference-count":35,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Postoperative neurological deficits impair the overall outcome of revascularization surgery for patients with moyamoya disease (MMD). <jats:sc>dl<\/jats:sc>-3-<jats:italic>n<\/jats:italic>-butylphthalide (NBP) is approved for the treatment of ischemic stroke in China. This pilot study evaluated the effect of NBP on perioperative stroke and neurological deficits in patients with MMD.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The authors studied cases in which patients underwent combined revascularization surgery for MMD at their institution, with or without NBP administration. The overall study group included 164 patients (213 surgically treated hemispheres), including 49 patients who received NBP (25 mg twice daily) for 7 postoperative days. The incidence of perioperative stroke and transient neurological deficit (TND) and the severity of neurological deficits were compared between 49 propensity score\u2013matched case pairs with or without NBP treatment. Subgroup analyses by type of onset and preoperative neurological status were also performed to determine specific characteristics of patients who might benefit from NBP administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>In the overall cohort, baseline characteristics differed with respect to preoperative stroke and modified Rankin Scale (mRS) score between patients who received NBP and those who did not receive it. In the 49 propensity score\u2013matched pairs, postoperative stroke was observed in 11 patients and TND occurred in 21 patients, with no significant difference in incidence between the 2 groups. However, the TND was less severe in the NBP-treated group (p = 0.01). At 1 month after surgery, the neurological outcome was more favorable (p = 0.001) and the disability-free recovery rate was higher in patients with NBP treatment (p &lt; 0.001). The number of patients who experienced an improved neurological function, compared to preoperative function, as measured by mRS, was greater in the NBP group than in the no-NBP group (p &lt; 0.001). Multivariable analysis revealed that NBP administration was associated with decreased severity of TND (OR 0.28, p = 0.02), improved neurological function (OR 65.29, p = 0.04), and lower postoperative mRS score (OR 0.06, p &lt; 0.001). These beneficial effects of NBP remained significant in ischemic type MMD and patients with preoperative mRS scores of 2 or greater.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Postoperative administration of NBP may alleviate perioperative neurological deficits after revascularization surgery for MMD, especially in patients with ischemic MMD and unfavorable preoperative status. The results of this study suggest that randomized controlled trials to assess the potential benefit of NBP in patients with MMD may be warranted.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2018.10.jns182152","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:56:38Z","timestamp":1554839798000},"page":"421-433","source":"Crossref","is-referenced-by-count":10,"title":["dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score\u2013matched analysis"],"prefix":"10.3171","volume":"132","author":[{"given":"Zongze","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Peking University International Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking University International Hospital;"},{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking University International Hospital;"},{"name":"Departments of Neurosurgery and"},{"name":"China National Clinical Research Center for Neurological Diseases;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxue","family":"Wu","sequence":"additional","affiliation":[{"name":"Neuroradiology, Beijing Tiantan Hospital, Capital Medical University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongsheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking University International Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking University International Hospital;"},{"name":"Departments of Neurosurgery and"},{"name":"China National Clinical Research Center for Neurological Diseases;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking University International Hospital;"},{"name":"Departments of Neurosurgery and"},{"name":"China National Clinical Research Center for Neurological Diseases;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking University International Hospital;"},{"name":"Departments of Neurosurgery and"},{"name":"China National Clinical Research Center for Neurological Diseases;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking University International Hospital;"},{"name":"Departments of Neurosurgery and"},{"name":"China National Clinical Research Center for Neurological Diseases;"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders; and"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/jcbfm.2014.217","article-title":"U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats","volume":"35","author":"Ahnstedt H","year":"2015","unstructured":"Ahnstedt H, Mostajeran M, Blixt FW, Warfvinge K, Ansar S, Krause DN, : U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats. J Cereb Blood Flow Metab 35:454\u2013460, 201510.1038\/jcbfm.2014.21725492115"},{"key":"b2","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3174\/ajnr.A4535","article-title":"Acute preoperative infarcts and poor cerebrovascular reserve are independent risk factors for severe ischemic complications following direct extracranial-intracranial bypass for moyamoya disease","volume":"37","author":"Antonucci MU","year":"2016","unstructured":"Antonucci MU, Burns TC, Pulling TM, Rosenberg J, Marks MP, Steinberg GK, : Acute preoperative infarcts and poor cerebrovascular reserve are independent risk factors for severe ischemic complications following direct extracranial-intracranial bypass for moyamoya disease. AJNR Am J Neuroradiol 37:228\u2013235, 201610.3174\/ajnr.A453526564435"},{"key":"b3","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1161\/STROKEAHA.114.005624","article-title":"Long-term outcomes after combined revascularization surgery in adult moyamoya disease","volume":"45","author":"Cho WS","year":"2014","unstructured":"Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, : Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke 45:3025\u20133031, 20142518435910.1161\/STROKEAHA.114.005624"},{"key":"b4","series-title":"Chin Med J (Engl)","first-page":"858","article-title":"Protective effects of dl-3-n-butylphthalide on changes of regional cerebral blood flow and blood-brain barrier damage following experimental subarachnoid hemorrhage","volume":"111","author":"Chong Z","year":"1998","unstructured":"Chong Z, Feng Y: Protective effects of dl-3-n-butylphthalide on changes of regional cerebral blood flow and blood-brain barrier damage following experimental subarachnoid hemorrhage. Chin Med J (Engl) 111:858\u2013860, 1998"},{"key":"b5","series-title":"Chin Med J (Engl)","first-page":"3405","article-title":"Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial","volume":"126","author":"Cui LY","year":"2013","unstructured":"Cui LY, Zhu YC, Gao S, Wang JM, Peng B, Ni J, : Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial. Chin Med J (Engl) 126:3405\u20133410, 2013"},{"key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3171\/2016.12.JNS162626","article-title":"Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study","volume":"128","author":"Deng X","year":"2018","unstructured":"Deng X, Gao F, Zhang D, Zhang Y, Wang R, Wang S, : Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study. J Neurosurg 128:1327\u20131337, 20182868611310.3171\/2016.12.JNS162626"},{"key":"b7","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.wneu.2017.01.039","article-title":"Disruption of cortical arterial network is associated with the severity of transient neurologic events after direct bypass surgery in adult moyamoya disease","volume":"100","author":"Egashira Y","year":"2017","unstructured":"Egashira Y, Yamauchi K, Enomoto Y, Nakayama N, Yoshimura S, Iwama T: Disruption of cortical arterial network is associated with the severity of transient neurologic events after direct bypass surgery in adult moyamoya disease. World Neurosurg 100:311\u2013315, 201710.1016\/j.wneu.2017.01.03928109863"},{"key":"b8","series-title":"Mol Neurobiol","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s12035-017-0746-5","article-title":"TiO2-nanowired delivery of DL-3-n-butylphthalide (DL-NBP) attenuates blood-brain barrier disruption, brain edema formation, and neuronal damages following concussive head injury","volume":"55","author":"Feng L","year":"2018","unstructured":"Feng L, Sharma A, Niu F, Huang Y, Lafuente JV, Muresanu DF, : TiO2-nanowired delivery of DL-3-n-butylphthalide (DL-NBP) attenuates blood-brain barrier disruption, brain edema formation, and neuronal damages following concussive head injury. Mol Neurobiol 55:350\u2013358, 20182885658610.1007\/s12035-017-0746-5"},{"key":"b9","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1227\/NEU.0000000000000238","article-title":"Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease","volume":"74","author":"Fujimura M","year":"2014","unstructured":"Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, : Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74:163\u2013170, 201410.1227\/NEU.000000000000023824176958"},{"key":"b10","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3171\/2014.10.JNS14231","article-title":"Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications","volume":"122","author":"Funaki T","year":"2015","unstructured":"Funaki T, Takahashi JC, Takagi Y, Kikuchi T, Yoshida K, Mitsuhara T, : Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications. J Neurosurg 122:400\u2013407, 20152542327110.3171\/2014.10.JNS14231"},{"key":"b11","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3171\/2009.4.JNS081649","article-title":"Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article","volume":"111","author":"Guzman R","year":"2009","unstructured":"Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, : Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111:927\u2013935, 20091946304610.3171\/2009.4.JNS081649"},{"key":"b12","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2015.10.JNS151022","article-title":"Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease","volume":"126","author":"Hamano E","year":"2017","unstructured":"Hamano E, Kataoka H, Morita N, Maruyama D, Satow T, Iihara K, : Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease. J Neurosurg 126:1\u20137, 201710.3171\/2015.10.JNS15102226894456"},{"key":"b13","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/2010.4.PEDS09478","article-title":"Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion","volume":"6","author":"Hayashi T","year":"2010","unstructured":"Hayashi T, Shirane R, Fujimura M, Tominaga T: Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr 6:73\u201381, 201010.3171\/2010.4.PEDS0947820593991"},{"key":"b14","series-title":"Alzheimers Dement","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jalz.2015.04.010","article-title":"The effects of dl-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: a multicentre, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Jia J","year":"2016","unstructured":"Jia J, Wei C, Liang J, Zhou A, Zuo X, Song H, : The effects of dl-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: a multicentre, randomized, double-blind, placebo-controlled trial. Alzheimers Dement 12:89\u201399, 20162608618310.1016\/j.jalz.2015.04.010"},{"key":"b15","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3171\/2014.1.JNS13946","article-title":"The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review","volume":"121","author":"Kazumata K","year":"2014","unstructured":"Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, : The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg 121:432\u2013440, 201410.3171\/2014.1.JNS1394624605834"},{"issue":"5 Suppl","key":"b16","series-title":"J Neurosurg","first-page":"433","article-title":"Risk factors for postoperative ischemic complications in patients with moyamoya disease","volume":"103","author":"Kim SH","year":"2005","unstructured":"Kim SH, Choi JU, Yang KH, Kim TG, Kim DS: Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg 103 (5 Suppl):433\u2013438, 200516302615"},{"key":"b17","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/jcbfm.2010.85","article-title":"Intraoperative blood flow analysis of direct revascularization procedures in patients with moyamoya disease","volume":"31","author":"Lee M","year":"2011","unstructured":"Lee M, Guzman R, Bell-Stephens T, Steinberg GK: Intraoperative blood flow analysis of direct revascularization procedures in patients with moyamoya disease. J Cereb Blood Flow Metab 31:262\u2013274, 20112058832110.1038\/jcbfm.2010.85"},{"key":"b18","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.brainres.2010.08.061","article-title":"dl-3-n-butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway","volume":"1359","author":"Li J","year":"2010","unstructured":"Li J, Li Y, Ogle M, Zhou X, Song M, Yu SP, : dl-3-n-butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway. Brain Res 1359:216\u2013226, 2010 (Erratum in Brain Res 1600:110, 2015)10.1016\/j.brainres.2010.08.06120800583"},{"key":"b19","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.brainres.2009.07.020","article-title":"dl-3-n-butylphthalide protects endothelial cells against oxidative\/nitrosative stress, mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitro","volume":"1290","author":"Li L","year":"2009","unstructured":"Li L, Zhang B, Tao Y, Wang Y, Wei H, Zhao J, : dl-3-n-butylphthalide protects endothelial cells against oxidative\/nitrosative stress, mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitro. Brain Res 1290:91\u2013101, 200910.1016\/j.brainres.2009.07.02019616517"},{"key":"b20","series-title":"J Neurol Sci","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jns.2007.04.025","article-title":"dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP","volume":"260","author":"Liu CL","year":"2007","unstructured":"Liu CL, Liao SJ, Zeng JS, Lin JW, Li CX, Xie LC, : dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP. J Neurol Sci 260:106\u2013113, 20071755352710.1016\/j.jns.2007.04.025"},{"key":"b21","series-title":"Int J Mol Sci","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms18112451","article-title":"Effects of Dl-3-n-butylphthalide on cerebral ischemia infarction in rat model by mass spectrometry imaging","volume":"18","author":"Liu RZ","year":"2017","unstructured":"Liu RZ, Fan CX, Zhang ZL, Zhao X, Sun Y, Liu HH, : Effects of Dl-3-n-butylphthalide on cerebral ischemia infarction in rat model by mass spectrometry imaging. Int J Mol Sci 18:18, 201710.3390\/ijms18112451"},{"key":"b22","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3171\/2014.10.JNS132369","article-title":"Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China","volume":"122","author":"Liu XJ","year":"2015","unstructured":"Liu XJ, Zhang D, Wang S, Zhao YL, Teo M, Wang R, : Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. J Neurosurg 122:392\u2013399, 201510.3171\/2014.10.JNS13236925423267"},{"key":"b23","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3171\/2014.8.JNS132413","article-title":"Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease?","volume":"122","author":"Mukerji N","year":"2015","unstructured":"Mukerji N, Cook DJ, Steinberg GK: Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease? J Neurosurg 122:90\u201394, 201510.3171\/2014.8.JNS13241325343178"},{"key":"b24","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.surneu.2007.01.047","article-title":"Postoperative temporary neurological deficits in adults with moyamoya disease","volume":"69","author":"Ohue S","year":"2008","unstructured":"Ohue S, Kumon Y, Kohno K, Watanabe H, Iwata S, Ohnishi T: Postoperative temporary neurological deficits in adults with moyamoya disease. Surg Neurol 69:281\u2013287, 200810.1016\/j.surneu.2007.01.04717996267"},{"key":"b25","series-title":"J Cereb Blood Flow","first-page":"271678X18776833","article-title":"Dl-3-N-butylphthalide attenuates ischemic reperfusion injury by improving the function of cerebral artery and circulation","volume":"Metab","author":"Qin C","year":"2018","unstructured":"Qin C, Zhou P, Wang L, Mamtilahun M, Li W, Zhang Z, : Dl-3-N-butylphthalide attenuates ischemic reperfusion injury by improving the function of cerebral artery and circulation. J Cereb Blood Flow Metab:271678X18776833, 2018"},{"key":"b26","series-title":"Am Stat","first-page":"33","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"Rosenbaum PR","year":"1985","unstructured":"Rosenbaum PR, Rubin DB: Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 39:33\u201338, 1985"},{"key":"b27","series-title":"J Cereb Blood Flow Metab","first-page":"1021","article-title":"Preoperatively reduced cerebrovascular contractile reactivity to hypocapnia by hyperventilation is associated with cerebral hyperperfusion syndrome after arterial bypass surgery for adult patients with cerebral misery perfusion due to ischemic moyamoya disease","volume":"38","author":"Sato S","year":"2018","unstructured":"Sato S, Kojima D, Shimada Y, Yoshida J, Fujimato K, Fujiwara S, : Preoperatively reduced cerebrovascular contractile reactivity to hypocapnia by hyperventilation is associated with cerebral hyperperfusion syndrome after arterial bypass surgery for adult patients with cerebral misery perfusion due to ischemic moyamoya disease. J Cereb Blood Flow Metab 38:1021\u20131031, 201829383984"},{"issue":"2 Suppl Pediatrics","key":"b28","series-title":"J Neurosurg","first-page":"142","article-title":"Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis","volume":"100","author":"Scott RM","year":"2004","unstructured":"Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100 (2 Suppl Pediatrics):142\u2013149, 200414758941"},{"key":"b29","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/STROKEAHA.116.013304","article-title":"Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study","volume":"47","author":"Uchino H","year":"2016","unstructured":"Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K: Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke 47:1930\u20131932, 20162717452610.1161\/STROKEAHA.116.013304"},{"key":"b30","series-title":"Acta Pharmacol Sin","first-page":"433","article-title":"Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats","volume":"21","author":"Xu HL","year":"2000","unstructured":"Xu HL, Feng YP: Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacol Sin 21:433\u2013438, 200011324442"},{"key":"b31","series-title":"Exp Ther Med","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3892\/etm.2016.3139","article-title":"Efficacy and safety comparison of DL-3-n-butylphthalide and cerebrolysin: effects on neurological and behavioral outcomes in acute ischemic stroke","volume":"11","author":"Xue LX","year":"2016","unstructured":"Xue LX, Zhang T, Zhao YW, Geng Z, Chen JJ, Chen H: Efficacy and safety comparison of DL-3-n-butylphthalide and cerebrolysin: effects on neurological and behavioral outcomes in acute ischemic stroke. Exp Ther Med 11:2015\u20132020, 20162716884410.3892\/etm.2016.3139"},{"key":"b32","series-title":"Platelets","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/09537104.2014.989826","article-title":"DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase","volume":"26","author":"Ye J","year":"2015","unstructured":"Ye J, Zhai L, Zhang S, Zhang Y, Chen L, Hu L, : DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase. Platelets 26:736\u2013744, 20152573421310.3109\/09537104.2014.989826"},{"key":"b33","series-title":"Neurol Res","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1179\/016164110X12670144526264","article-title":"3-n-butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats","volume":"32","author":"Zhang T","year":"2010","unstructured":"Zhang T, Jia W, Sun X: 3-n-butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats. Neurol Res 32:390\u2013396, 20102048300610.1179\/016164110X12670144526264"},{"key":"b34","series-title":"J Stroke Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.018","article-title":"Mobilization of circulating endothelial progenitor cells by dl-3-n-butylphthalide in acute ischemic stroke patients","volume":"25","author":"Zhao H","year":"2016","unstructured":"Zhao H, Yun W, Zhang Q, Cai X, Li X, Hui G, : Mobilization of circulating endothelial progenitor cells by dl-3-n-butylphthalide in acute ischemic stroke patients. J Stroke Cerebrovasc Dis 25:752\u2013760, 20162677526810.1016\/j.jstrokecerebrovasdis.2015.11.018"},{"key":"b35","series-title":"J Neurosurg","article-title":"Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease","author":"Zhao M","unstructured":"Zhao M, Deng X, Zhang D, Wang S, Zhang Y, Wang R, : Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. J Neurosurg [epub ahead of print March 30, 2018. DOI: 10.3171\/2017.10.JNS171749]"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/132\/2\/article-p421.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/132\/2\/article-p421.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/132\/2\/article-p421.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T08:45:38Z","timestamp":1658738738000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/132\/2\/article-p421.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":35,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2018.10.jns182152","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}